ChinaBio® Executive Workshop
Building Company Value Through Global Partnerships
You are invited to attend the “Building Company Value Through Global Partnerships” Executive Workshop as the guest of our hosts and sponsors: Foley & Lardner LLP, ChinaBio® Accelerator, Guangzhou Economic & Technological Development District and Guangzhou Biotechnology Center.
This workshop addresses three critical topics for life science executives, entrepreneurs and investors wishing to leverage global partnerships to help fund the growth of their companies:
?Understanding the differences between China and western law
?Positioning your business and IP portfolio with potential partners and investors
China’s life science industry is moving quickly from services to innovation. Hear the latest update on novel technology development, investment, M&A and partnering deals, and other data from ChinaBio’s research team.
Join other key executives and managers of biotechnology and life science companies interested in learning how to leverage China to raise investment funds, develop new drugs or medical devices, generate global intellectual property rights, and manage global clinical trials. Learn “how to do it” from our speakers who are all senior executives who have successfully put their principles into practice in the real world. Also meet other executives and managers from companies facing the same issues as you.
Stephen A. Bent, JD - Partner, Foley & Lardner LLP
Stephen A. Bent, a partner with Foley & Lardner LLP, is a member of the Chemical, Biotechnology & Pharmaceutical Practice and the Health Care and Nanotechnology Industry Teams. He is the founder and a former co-chair of the Life Sciences Industry Team. Mr. Bent counsels clients on intellectual property disputes and the legal issues associated with pharmaceutical and biotechnology asset valuation and management, venture capital, licensing and technology transfer, and corporate acquisitions. He is a principal in the firm’s China initiative and is active in Foley & Lardner’s Shanghai office.
James C. Chapman, JD, MBA - Partner, Foley & Lardner LLP
James C. Chapman is a partner with Foley & Lardner LLP where he focuses on securities law, venture capital, mergers and acquisitions, and international business transactions. Mr. Chapman has more than 20 years experience in corporate and securities law and has been involved in over 200 mergers, acquisitions, and financing transactions. These transactions have included public offerings, private placements, debt financings, venture capital transactions, stock sales, asset sales, mergers, reorganizations, and recapitalizations. He is a member of the firm’s Private Equity & Venture Capital Practice and the Emerging Technologies Industry Team.
James F. Ewing, JD, PhD - Partner, Foley & Lardner LLP
James F. Ewing is vice chair of the Chemical, Biotechnology & Pharmaceutical Practice and a member of the Life Sciences, Food and Nanotechnology Industry Teams. Dr. Ewing primarily advises pharmaceutical, biotechnology, and nutraceutical clients. In the pharmaceutical and biotechnology sectors, Dr. Ewing works with companies engaged in drug discovery to develop and produce peptide and small molecule therapeutics, encompassing such technologies as computationally assisted drug design, immunology and vaccine technologies, stem cell technologies, neurobiology, drug delivery, gene therapy technologies, nanobiology technologies and biomedical devices.
Greg B. Scott - President and Founder, ChinaBio® LLC
Mr. Scott has helped launch over thirty life science startups in the U.S. and China as a founder, investor and advisor. He founded ChinaBio® LLC in January 2007 to help fund and mentor early stage life science companies in China, and provide consulting and research services to pharma and biotech companies with business interests in China. Most recently, Mr. Scott is also the president and co-founder of Life Science Angels, an angel investment group that has funded 30 biotechnology and medical device companies, and executive editor of ChinaBio® Today. He previously held senior executive positions at Price Waterhouse, Capgemini and MCI.
This ChinaBio® Executive Workshop – Guangzhou will be held at:
For driving directions, please contact the hotel.
We would like to thank the following sponsors for making this event possible:
About ChinaBio® Accelerator
ChinaBio® Accelerator was created to accelerate the globalization of China's biotechnology industry by:
ChinaBio is identifying promising biotech and medical device investment opportunities in China and providing the capital, connections and leadership to help entrepreneurs realize their vision. www.ChinaBioLLC.com
Copyright © 2017, ChinaBio® LLC - ChinaBio is a registered trademark of ChinaBio® LLC